Jiang Zhong Pharmaceutical Co.,Ltd provided earning guidance for the quarter ended March 31, 2022. for the quarter, the company is expected to have a total operating income of approximately RMB 890 million, representing a year-on-year increase of approximately 30% and the net profit attributable to shareholders of the listed company is expected to be approximately RMB180 million, representing a year-on-year increase of approximately 11%.